Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes
Abstract Background Gliomas evade current therapies through primary and acquired resistance and the effect of temozolomide is mainly restricted to methylguanin‐O6-methyltransferase promoter (MGMT) promoter hypermethylated tumors. Further resistance markers are largely unknown and would help for bett...
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-11-01
|
Series: | Cancer Medicine |
Online Access: | https://doi.org/10.1002/cam4.3447 |